torsemide has been researched along with Cardiac Failure in 132 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.27) | 18.7374 |
| 1990's | 25 (18.94) | 18.2507 |
| 2000's | 44 (33.33) | 29.6817 |
| 2010's | 37 (28.03) | 24.3611 |
| 2020's | 23 (17.42) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Galicia, M; Bailey, T; Brochu, RM; de Jesus, RK; Ding, FX; Ehrhart, J; Felix, JP; Garcia, ML; Gu, X; Ha, S; Hampton, C; Hernandez, M; Jiang, J; Kaczorowski, GJ; Owens, K; Pai, LY; Parmee, ER; Pasternak, A; Pio, B; Priest, BT; Roy, S; Shahripour, A; Sullivan, K; Swensen, AM; Tang, H; Teumelsan, N; Thomas-Fowlkes, B; Walsh, SP; Yang, L; Zhou, X; Zhu, Y | 1 |
| DeWald, TA; Greene, SJ; Mentz, RJ; Peters, AE | 1 |
| Bell, R; Bruce, S; Cooper, LB; deFilippi, C; Mentz, R; O'Connor, C; Psotka, M; Seliger, SL | 1 |
| Anstrom, KJ; Eisenstein, EL; Greene, SJ; Harding, T; Harrington, A; Kim, DY; Mentz, RJ; Sachdev, V; Sapp, S; Velazquez, EJ | 1 |
| Fukuda, K; Goda, A; Imaeda, S; Kohno, T; Kohsaka, S; Nagatomo, Y; Nakano, S; Niimi, N; Saji, M; Shiraishi, Y; Takei, M; Yoshikawa, T | 1 |
| Menon, V; Verbrugge, FH | 1 |
| Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harrington, AH; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Testani, JM; Velazquez, EJ | 1 |
| DeWald, TA; Mentz, RJ; Velazquez, EJ | 1 |
| Wolowich, WR | 1 |
| Alexy, T; Ambrosy, AP; Anstrom, KJ; Clare, RM; Desvigne-Nickens, P; DeWald, TA; Eisenstein, EL; Greene, SJ; Ketema, F; Kim, DY; Mentz, RJ; Pitt, B; Psotka, MA; Rommel, JJ; Stevens, GR; Velazquez, EJ | 1 |
| Kulkarni, NS | 1 |
| Al-Habbaa, A; Eid, PS; Elkady, AH; Elsayed, GG; Elshafay, A; Hirayama, K; Huy, NT; Kien, ND; Minh, LHN; Mohammed, AT; Morra, ME; Nghia, TLB; Sherif, NA; Thanh, LV; Turk, T; Y, MN | 1 |
| Bakuła, E; Balsam, P; Bednarski, J; Cacko, A; Filipiak, KJ; Fojt, A; Gawałko, M; Grabowski, M; Główczyńska, R; Kowalik, R; Marchel, M; Markulis, M; Niedziela, Ł; Niewiński, G; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Sieradzki, M; Tymińska, A | 1 |
| Baduashvili, A | 1 |
| Chan, JSK; Harky, A | 1 |
| Badriddinova, L; Berechikidze, I; Kukes, V; Pavlova, L; Shikh, E; Tsvetkov, D | 1 |
| Haeberle, M; Karle, CA | 1 |
| Besche, B; Blondel, T; Garelli-Paar, C; Guillot, E; Oyama, MA | 1 |
| Abouibrahim, MA; Do, VBD; Duy, LM; Eid, PS; Elfaituri, MK; Elrahman, MMA; Fahmy, MM; Hirayama, K; Huy, NT; Ibrahim, DA; Kandil, H; Minh, LHN; Shah, J; Shehata, MAA; Shinkar, A; Tam, DNH; Vuong, NL; Zayan, AH | 1 |
| Alvarado, MP; Barbarino, A; Chetboul, V; Delle Cave, J; Depré, B; Ghazal, S; Lefort, S; Marchal, CR; Passavin, P; Poissonnier, C; Saponaro, V; Tissier, R; Trehiou-Sechi, E; Vannucci, E; Verwaerde, P | 1 |
| Hu, J; Jiang, L; Li, M; Wan, Q; Yuan, F; Zhang, Y; Zhou, J | 1 |
| Paulus, R; Schmidt, B | 1 |
| Guo, Z; Li, L; Li, Y; Zhang, S | 1 |
| Anstrom, KJ; Desvigne-Nickens, P; Eisenstein, EL; Greene, SJ; Harding, T; Ketema, F; Kim, DY; Mentz, RJ; Morgan, S; Pitt, B; Sachdev, V; Sapp, S; Velazquez, EJ | 1 |
| Bletskan, ММ; Ivano, NV; Korabelschykova, MO; Rоsul, ММ | 1 |
| Blanc, J; Chetboul, V; Desquilbet, L; Lucats, L; Menard, J; Petit, A; Pouchelon, JL; Rougier, S; Woehrle, F | 1 |
| Greene, SJ; Mentz, RJ | 1 |
| Yao, Y; Zhang, J; Zhang, R; Zhang, Y | 1 |
| Doshi, R; Mithawala, P; Patel, H; Shah, P | 1 |
| Balsam, P; Crespo-Leiro, MG; Drożdż, J; Filipiak, KJ; Grabowski, M; Kapłon-Cieślicka, A; Kowalik, R; Maggioni, AP; Marchel, M; Opolski, G; Ozierański, K; Peller, M; Tymińska, A; Wancerz, A | 1 |
| Anstrom, KJ; Eisenstein, EL; Gabriel, D; Greene, SJ; Harding, T; Harrington, A; Jones, I; Mentz, RJ; Prather, K; Velazquez, EJ | 1 |
| Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Schellberg, D; Seiz, M; Täger, T | 1 |
| Chen, M; Hanumanthu, BK; Kokkinidis, DG; Miles, JA; Patel, K; Siegel, RM | 1 |
| Ahmed, D; Assi, AAR; Habra, M; Rahhal, A; Saad, MO; Tawengi, K | 1 |
| Bikdeli, B; Coca, SG; Dharmarajan, K; Khan, U; Kim, N; Krumholz, HM; Li, SX; Partovian, C; Strait, KM; Testani, JM | 1 |
| Cicoira, M; Dini, FL; Genta, FT; Ghio, S; Klersy, C; Rossi, A; Scelsi, L; Simioniuc, A; Tavazzi, L; Temporelli, PL | 1 |
| Afanas'ev, SA; Nevdakh, AE; Repin, AN; Rogovskaia, IuB | 1 |
| Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA | 1 |
| Arutiunov, GP; Dragunov, DO; Sokolova, AV | 1 |
| Kiiakbaev, GK; Kobalava, ZhD | 1 |
| Ding, GL; Guo, SL; Han, LN; Lin, XM; Shi, XM; Yang, LM; Zang, CB | 1 |
| Arutiunov, AG; Arutiunov, GP; Dragunov, DO; Rylova, AK; Sokolova, AV | 1 |
| Anstrom, KJ; Buggey, J; Eisenstein, EL; Mentz, RJ; O'Connor, CM; Pitt, B; Velazquez, EJ | 1 |
| Drożdż, J; Filipiak, KJ; Mamcarz, A; Nessler, J; Niemczyk, M; Tykarski, A; Wożakowska-Kapłon, B | 1 |
| Frolkina, MO; Shiriaev, IV; Shtegman, OA | 1 |
| Anstrom, KJ; Buggey, J; DeVore, AD; Eisenstein, EL; Ersbøll, MK; Fiuzat, M; Mentz, RJ; OʼConnor, CM; Schulte, PJ; Velazquez, EJ | 1 |
| Antonijoan, RM; Ballester, MR; Delgadillo, J; Gich, I; Puntes, M; Roig, E; Santos, B | 1 |
| Chiswell, K; Fiuzat, M; Givertz, MM; McKendry, C; Mentz, RJ; Metra, M; O'Connor, CM; Teerlink, JR; Velazquez, EJ; Voors, AA | 1 |
| Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA | 1 |
| Díez, J; Weber, KT | 1 |
| Antony, S; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Bakuła, E; Balsam, P; Cacko, A; Filipiak, KJ; Fojt, A; Grabowski, M; Główczyńska, R; Huczek, Z; Kowalik, R; Markulis, M; Opolski, G; Ozierański, K; Peller, M; Sieradzki, B; Tymińska, A | 1 |
| Baughman, KL; Desai, AS; Fang, JC; Givertz, MM; Lewis, EF; Mielniczuk, LM; Nohria, A; Stevenson, LW; Tsang, SW | 1 |
| Ishido, H; Senzaki, H | 1 |
| Beaumont, J; Díez, J; González, A; Larman, M; López, B; Querejeta, R | 2 |
| Anguita, M; Castillo, JC; León, C; Toledano, F | 1 |
| Nicklas, J; Pitt, B | 1 |
| Cheng, XW; Harada, K; Hirashiki, A; Isobe, S; Izawa, H; Kobayashi, M; Murase, Y; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Yokota, M | 1 |
| Aizawa, Y; Harima, M; Kodama, M; Tachikawa, H; Tanaka, H; Thanikachalam, PV; Watanabe, K; Yamaguchi, K | 1 |
| Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E | 1 |
| Corti, N; Elke, B; Locher, P; Wagner, CC | 1 |
| Fromm, MF; Graf, B; Heinbüchner, S; Ince, H; Kische, S; König, J; Thürmann, P; Werner, D; Werner, U; Zolk, O | 1 |
| Brooks, N; Clark, AL; Clayton, N; Gandhi, N; Gupta, S; Keevil, B; Neyses, L; Ng, LL; Waywell, C | 1 |
| Davis, RC; MacFadyen, RJ; Ng Kam Chuen, MJ | 1 |
| Acuña, C | 1 |
| Arystanova, A; Khoseva, EN; Nekrasova, NI; Pataraia, SA; Preobrazhenskiĭ, DV; Talyzina, IV | 1 |
| Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE | 1 |
| Machen, MC; Oyama, MA; Peddle, GD; Reynolds, CA; Singletary, GE; Trafny, DJ | 1 |
| Cosín, J; Díez, J | 1 |
| Falkenstein, P; Follath, F; Gutzwiller, F; Müller, K; Reitberger, U; Spannheimer, A | 1 |
| Bigner, D; Craig, S; Wall, GC | 1 |
| Akutagawa, O; Fukuda, M; Hayashi, T; Honda, K; Okamoto, M; Sasaki, T; Yamato, M | 1 |
| Grajewska, M; Manitius, J; Sulikowska, B | 1 |
| Gamba, G; Hess, B; Jaquet, F; Müller, K | 1 |
| Díez, J; González, A; Larman, M; López, B; Querejeta, R; Sánchez, E | 1 |
| Dohke, T; Fujii, M; Horie, M; Ishikawa, C; Ohno, K; Sakai, H; Takayama, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Yamamoto, T; Yano, M | 1 |
| Hatori, T; Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Eshaghian, S; Fonarow, GC; Horwich, TB | 1 |
| Chuen, MJ; MacFadyen, RJ | 1 |
| Batyraliev, TA; Marenich, AV; Preobrazhenskiĭ, DV; Sidorenko, BA; Tarykina, EV | 1 |
| Caro-Vadillo, A; Montoya-Alonso, JA; Ynaraja-Ramírez, E | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Cantarovich, F; Hoste, E; Mehta, RL; Murray, P; Shaw, A | 1 |
| Ishido, H; Kamiyama, M; Katogi, T; Kobayashi, T; Kyo, S; Masutani, S; Senzaki, H; Taketazu, M | 1 |
| Dodion, L; Kesteloot, H; Stroobandt, R | 1 |
| Brater, DC | 2 |
| Adams, KF; Blose, JS; Patterson, JH | 1 |
| Brogden, RN; Dunn, CJ; Fitton, A | 1 |
| Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, DL | 1 |
| Kramer, WG | 1 |
| Ploch, T; Podszus, T; Wagner, U | 1 |
| Casali, E; Castellani, ET; Mattioli, AV; Mattioli, G | 1 |
| Black, PK; Brater, DC; Kramer, WG; Serpas, T; Smith, WB; Vargo, D | 1 |
| Bremner, S; Hariman, RJ; Jones, JP; Kostis, JB; Louie, EK; Nocero, MA; Rogers, WJ | 1 |
| Leary, WP; Reyes, AJ | 1 |
| Silke, B | 1 |
| Reyes, AJ | 1 |
| Fowler, SF; Murray, KM | 1 |
| Black, PK; Brater, DC; Ferguson, J; Grant, AG; Kramer, WG; Serpas, T; Smith, WB | 1 |
| Medert, G; Wittig, T | 1 |
| Fisher, ML; Gottlieb, SS; Khatta, M; Kramer, WG; Roffman, D; Wentworth, D | 1 |
| Bleske, BE; Kramer, WG; Nicklas, JM; Welage, LS | 1 |
| Gorriz-Teruel, JL; Martínez-Mir, I; Pallardó-Mateu, LM; Palop-Larrea, V; Sancho-Calabuig, A | 1 |
| Berman, BN; Bryant, J; Heaton, AH; Trotter, JP | 1 |
| Andreini, I; Casini, A; Di Loreto, M; Liguori, A; Napoli, C | 1 |
| Noe, LL; Pezzella, SM; Trotter, JP; Vreeland, MG | 1 |
| Dreckmann-Behrendt, B; Goertz, A; Spannheimer, A | 1 |
| Brater, DC; Forthofer, MM; Murray, MD; Stroupe, KT | 1 |
| Plosker, GL; Young, M | 1 |
| Kido, H; Ohtaki, Y | 1 |
| Adams, LD; Bennett, SJ; Brater, DC; Deer, MM; Dexter, PR; Ferguson, JA; Lane, KA; Murray, MD; Perkins, SM; Smith, FE; Tierney, WM | 1 |
| Cohn, JN | 1 |
| Buckley, MM; Friedel, HA | 1 |
| Achhammer, I; Glocke, M; Häcker, W | 1 |
| Delarge, J; Luyckx, AS; Scheen, AJ; Vancrombreucq, JC | 1 |
29 review(s) available for torsemide and Cardiac Failure
| Article | Year |
|---|---|
An evaluation of torsemide in patients with heart failure and renal disease.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Multicenter Studies as Topic; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2022 |
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome | 2020 |
[PHARMACOGENETIC ASPECTS OF TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE (REVIEW)].
Topics: Adrenergic beta-Antagonists; Diuretics; Heart Failure; Humans; Pharmacogenetics; Torsemide | 2020 |
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies; Randomized Controlled Trials as Topic; Torsemide; Treatment Outcome | 2021 |
Torsemide versus furosemide in heart failure patients: A meta-analysis of randomized controlled trials.
Topics: Furosemide; Heart Failure; Humans; Patient Readmission; Randomized Controlled Trials as Topic; Time Factors; Torsemide; Treatment Outcome | 2018 |
Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Topics: Furosemide; Heart Failure; Humans; Observational Studies as Topic; Patient Readmission; Randomized Controlled Trials as Topic; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
[Ways of optimizing diuretic therapy in congestive heart failure, chronic place torasemide prolonged release].
Topics: Delayed-Action Preparations; Diuretics; Dose-Response Relationship, Drug; Drug Monitoring; Heart Failure; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2014 |
A reappraisal of loop diuretic choice in heart failure patients.
Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, Physicians'; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Up-Regulation; Ventricular Dysfunction, Left | 2015 |
Torasemide for the treatment of heart failure.
Topics: Animals; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Quality of Life; Sulfonamides; Torsemide | 2008 |
[Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Echocardiography, Doppler; Furosemide; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Meta-Analysis as Topic; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Torsemide | 2008 |
[Frequent drug interactions in old age].
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Depression; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Metoprolol; Paroxetine; Polypharmacy; Risk Factors; Sulfonamides; Torsemide | 2009 |
[Update: prolonged-release torasemide].
Topics: Animals; Chronic Disease; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2010 |
[Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].
Topics: Biological Availability; Blood Pressure; Chronic Disease; Dose-Response Relationship, Drug; Half-Life; Heart Failure; Humans; Hyperglycemia; Hypertension; Hypokalemia; Loop of Henle; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Ethacrynic acid and the sulfa-sensitive patient.
Topics: Aged; Diuretics; Drug Administration Schedule; Drug Hypersensitivity; Ethacrynic Acid; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Tubules; Male; Sulfonamides; Torsemide | 2003 |
[Torasemide (Trifas) in clinical practice--own experience].
Topics: Acute Kidney Injury; Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Sulfonamides; Torsemide | 2003 |
[Aldosterone antagonist therapy for chronic heart failure].
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Randomized Controlled Trials as Topic; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2005 |
[Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].
Topics: Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2006 |
Pharmacokinetics and pharmacodynamics of torasemide in health and disease.
Topics: Diuretics; Heart Failure; Humans; Kidney Diseases; Sulfonamides; Torsemide | 1993 |
Torsemide: a pyridine-sulfonylurea loop diuretic.
Topics: Clinical Trials as Topic; Diuretics; Drug Interactions; Furosemide; Heart Failure; Humans; Liver Cirrhosis; Renal Insufficiency; Sulfonamides; Torsemide | 1995 |
Torasemide. An update of its pharmacological properties and therapeutic efficacy.
Topics: Age Factors; Animals; Clinical Trials as Topic; Diuretics; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Hypertension; Liver Cirrhosis; Renal Insufficiency; Sulfonamides; Torsemide | 1995 |
Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.
Topics: Diuretics; Heart Failure; Humans; Sulfonamides; Torsemide | 1994 |
Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
Topics: Calcium; Chlorides; Diuretics; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Natriuresis; Potassium; Sodium; Sulfonamides; Torsemide | 1993 |
Central hemodynamic effects of diuretic therapy in chronic heart failure.
Topics: Bumetanide; Cardiac Output; Diuresis; Diuretics; Furosemide; Heart Failure; Hemodynamics; Humans; Muzolimine; Plasma Volume; Sulfonamides; Torsemide | 1993 |
Diuretics in cardiovascular medicine: new wine into old bottles. Presentation of the fundamentals.
Topics: Diuretics; Electrolytes; Heart Failure; Humans; Hypertension; Natriuresis; Sulfonamides; Torsemide | 1993 |
Torsemide: a new loop diuretic.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hypertension; Sulfonamides; Torsemide | 1995 |
Benefits and risks of torasemide in congestive heart failure and essential hypertension.
Topics: Antihypertensive Agents; Diuretics; Drug Interactions; Half-Life; Heart Failure; Hemodynamics; Humans; Hypertension; Sulfonamides; Torsemide | 1996 |
[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].
Topics: Animals; Clinical Trials as Topic; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Humans; Hypokalemia; Mineralocorticoid Receptor Antagonists; Sulfonamides; Torsemide | 2001 |
Torasemide. A review of its pharmacological properties and therapeutic potential.
Topics: Animals; Diuretics; Half-Life; Heart Failure; Hemodynamics; Humans; Hypertension; Kidney; Sulfonamides; Tissue Distribution; Torsemide | 1991 |
42 trial(s) available for torsemide and Cardiac Failure
| Article | Year |
|---|---|
Ascertaining Death Events in a Pragmatic Clinical Trial: Insights From the TRANSFORM-HF Trial.
Topics: Furosemide; Heart Failure; Humans; Reproducibility of Results; Torsemide; United States | 2022 |
Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Discharge; Sodium Potassium Chloride Symporter Inhibitors; Torsemide; Treatment Outcome | 2023 |
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
Topics: Furosemide; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Torsemide | 2023 |
Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Topics: Aged; Comparative Effectiveness Research; Exercise Tolerance; Female; Furosemide; Heart Failure; Humans; Male; Pilot Projects; Poland; Preliminary Data; Recovery of Function; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Male; Mitral Valve; Sulfonamides; Torsemide | 2020 |
Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure with volume overload: a prospective, randomized, controlled clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; China; Female; Fluid Shifts; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Torsemide; Treatment Outcome; Ultrafiltration; Urination; Weight Loss | 2020 |
Comparative effectiveness of furosemide vs torasemide in symptomatic therapy in heart failure patients: A randomized controlled study protocol.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; Torsemide | 2021 |
Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Topics: Animals; Diuretics; Dogs; Female; Furosemide; Heart Failure; Heart Valve Diseases; Male; Mitral Valve; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2017 |
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines | 2014 |
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue].
Topics: Adult; Angiotensin II; Chronic Disease; Delayed-Action Preparations; Female; Half-Life; Heart Failure; Humans; Hypertension; Kidney Tubules; Male; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2014 |
[Effect of dosage forms loop diuretic with a different release rate for early and delayed the prognosis of patients with circulatory decompensation].
Topics: Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Treatment Outcome; Water-Electrolyte Balance | 2014 |
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Chronic Disease; Cross-Over Studies; Delayed-Action Preparations; Furosemide; Heart Failure; Humans; Middle Aged; Natriuresis; Sodium Potassium Chloride Symporter Inhibitors; Spain; Sulfonamides; Time Factors; Torsemide; Treatment Outcome; Urination | 2015 |
Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
Topics: Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Survival Rate; Time Factors; Torsemide; Treatment Outcome | 2015 |
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Furosemide; Global Health; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2016 |
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Topics: Biomarkers; Chronic Disease; Clinical Protocols; Echocardiography; Electrocardiography, Ambulatory; Furosemide; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Poland; Quality of Life; Recovery of Function; Research Design; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Surveys and Questionnaires; Time Factors; Torsemide; Treatment Outcome; Ventricular Remodeling; Walk Test | 2017 |
Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.
Topics: Aged; Collagen; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardium; Prospective Studies; Protein-Lysine 6-Oxidase; Sulfonamides; Torsemide; Ultrasonography; Up-Regulation; Ventricular Dysfunction, Left | 2009 |
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
Topics: Administration, Oral; Aldosterone; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Norepinephrine; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides; Sulfonamides; Sympathetic Nervous System; Systole; Torsemide; Ventricular Dysfunction, Left | 2009 |
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Procollagen; Prospective Studies; Research Design; Sulfonamides; Torsemide | 2009 |
Gender is an important determinant of the disposition of the loop diuretic torasemide.
Topics: Cell Line; Diuretics; Female; Heart Failure; Humans; Hypertension; Liver-Specific Organic Anion Transporter 1; Male; Mutagenesis, Site-Directed; Organic Anion Transporters; Polymorphism, Genetic; Sex Factors; Sulfonamides; Torsemide | 2010 |
The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Intention to Treat Analysis; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prognosis; Quality of Life; Renin; Retrospective Studies; Sulfonamides; Systole; Torsemide; Ventricular Dysfunction, Left | 2010 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; Female; Fibrosis; Furosemide; Heart Failure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Procollagen; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
Topics: Animals; Cross-Over Studies; Diuretics; Dog Diseases; Dogs; Furosemide; Heart Failure; Mitral Valve Insufficiency; Sulfonamides; Torsemide | 2012 |
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography, Doppler; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Regression Analysis; Sulfonamides; Torsemide; Ventricular Dysfunction, Left | 2003 |
Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome | 2003 |
Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.
Topics: Collagen Type I; Diuretics; Echocardiography; Endomyocardial Fibrosis; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pilot Projects; Sulfonamides; Torsemide; Treatment Outcome | 2004 |
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardium; Sulfonamides; Torsemide | 2004 |
Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Topics: Aged; Autonomic Nervous System Diseases; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Observer Variation; Stroke Volume; Sulfonamides; Tomography, Emission-Computed, Single-Photon; Torsemide; Ventricular Remodeling | 2006 |
Effect of torsemide on serum and urine electrolyte levels in dogs with congestive heart failure.
Topics: Animals; Antihypertensive Agents; Dog Diseases; Dogs; Electrolytes; Heart Failure; Sulfonamides; Torsemide | 2007 |
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Myocardium; Peptide Fragments; Pilot Projects; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Torsemide | 2007 |
Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide | 1982 |
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biological Availability; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Sulfonamides; Torsemide | 1995 |
Clinical and haemodynamic effects of long-term treatment with torasemide in congestive heart failure.
Topics: Diuretics; Exercise Test; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Sulfonamides; Torsemide | 1994 |
Symptomatic achievements with diuretics in congestive heart failure.
Topics: Diuretics; Exercise Test; Female; Furosemide; Heart Failure; Humans; Jugular Veins; Male; Middle Aged; Sulfonamides; Torsemide; Venous Pressure | 1994 |
The pharmacodynamics of torsemide in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Diuretics; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide | 1994 |
Dose-response study of intravenous torsemide in congestive heart failure.
Topics: Adult; Aged; Chlorides; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Potassium; Sodium; Sulfonamides; Torsemide; Urine | 1994 |
Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
Topics: Adult; Diuretics; Female; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Natriuresis; Sulfonamides; Torsemide | 1996 |
Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure.
Topics: Area Under Curve; Chromatography, High Pressure Liquid; Creatinine; Diuretics; Half-Life; Heart Failure; Hemodynamics; Humans; Sodium; Sulfonamides; Torsemide | 1998 |
A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure.
Topics: Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Managed Care Programs; Quality of Life; Random Allocation; Sulfonamides; Surveys and Questionnaires; Torsemide | 1999 |
Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Topics: Adult; Aged; Diuretics; Drug Costs; Female; Furosemide; Health Care Costs; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsemide | 2000 |
Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
Topics: Aged; Biological Availability; Diuretics; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Quality of Life; Sulfonamides; Torsemide; Treatment Outcome | 2001 |
Efficacy and safety of torasemide in patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pulse; Random Allocation; Sulfonamides; Torsemide; Water-Electrolyte Balance | 1988 |
Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.
Topics: Aged; Calcium; Chronic Disease; Creatinine; Diuretics; Double-Blind Method; Drug Evaluation; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Osmolar Concentration; Phosphates; Random Allocation; Sulfonamides; Torsemide; Urine | 1986 |
61 other study(ies) available for torsemide and Cardiac Failure
| Article | Year |
|---|---|
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.
Topics: Animals; Diuresis; Dogs; Heart Failure; Humans; Hypertension; Macaca mulatta; Oxazines; Potassium Channels, Inwardly Rectifying; Rats, Sprague-Dawley; Transcriptional Regulator ERG | 2016 |
Proteomic differences among patients with heart failure taking furosemide or torsemide.
Topics: Diuretics; Female; Furosemide; Heart Failure; Humans; Proteomics; Torsemide | 2022 |
Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Topics: Aged; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2022 |
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Torsemide; Treatment Outcome | 2022 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure-Reply.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
Torsemide vs Furosemide After Discharge and All-Cause Mortality in Patients With Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Patient Discharge; Sulfonamides; Torsemide | 2023 |
No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart Failure.
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2023 |
Simpson's Paradox: Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure.
Topics: Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Torsemide | 2020 |
Simpson's Paradox in Meta-Analysis - Choice of Studies and Summary Statistics.
Topics: Data Interpretation, Statistical; Furosemide; Heart Failure; Humans; Torsemide | 2020 |
Photodermatitis caused by torasemide.
Topics: Aged; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrochlorothiazide; Lymphedema; Molecular Structure; Photosensitivity Disorders; Torsemide | 2021 |
Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019).
Topics: Animals; Cat Diseases; Cats; Diuretics; Female; Furosemide; Heart Failure; Male; Retrospective Studies; Torsemide; Treatment Outcome | 2020 |
90-year-old man • dyspnea • lower extremity edema • limitations in daily activities • Dx?
Topics: Activities of Daily Living; Aged, 80 and over; Diagnosis, Differential; Diuretics; Dyspnea; Edema; Female; Heart Failure; Humans; Lisinopril; Lower Extremity; Metoprolol; Obesity; Spironolactone; Torsemide | 2020 |
LOOP DIURETICS IN HEART FAILURE: EVIDENCE-BASED CHOICE.
Topics: Diuretics; Heart Failure; Humans; Quality of Life; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2021 |
Potential advantages of torsemide in patients with heart failure: more than just a 'water pill'?
Topics: Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water | 2018 |
Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
Topics: Aged; China; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Proportional Hazards Models; Sulfonamides; Torsemide | 2018 |
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Topics: Aged; Disease Progression; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Poland; Recovery of Function; Registries; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Death: The Simple Clinical Trial Endpoint.
Topics: Clinical Trials as Topic; Data Collection; Diuretics; Endpoint Determination; Furosemide; Heart Failure; Humans; Mortality; Torsemide | 2019 |
Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Topics: Aged; Blood Pressure; Bumetanide; Cause of Death; Europe; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left | 2019 |
Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
Topics: Aged; Drug Substitution; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Patient Readmission; Qatar; Retrospective Studies; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Torsemide; Treatment Outcome | 2019 |
Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?
Topics: Databases, Factual; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Survival Analysis; Torsemide; Treatment Outcome | 2013 |
Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Propensity Score; Renal Insufficiency, Chronic; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ventricular Dysfunction, Left; Young Adult | 2013 |
[Influence of the long-term administration of torasemide on morphometric characteristics of cardiac muscle under conditions of developed experimental postinfarction cardiosclerosis].
Topics: Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Drug Administration Schedule; Endocardium; Endomyocardial Fibrosis; Heart Failure; Histocytochemistry; Myocardium; Rats; Rats, Wistar; Sulfonamides; Torsemide; Treatment Failure | 2013 |
Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disease Progression; Diuretics; Echocardiography, Doppler, Color; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Incidence; Male; Middle Aged; Prognosis; Sulfonamides; Torsemide; Treatment Outcome | 2014 |
[Loop diuretics: old and new ones--which one to choose in clinical practice? Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy and Working Group on Heart Failure].
Topics: Cardiology; Furosemide; Heart Failure; Humans; Poland; Societies, Medical; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2015 |
[Test with torasemide in the differential diagnosis of dyspnea in patients with cardiovascular diseases].
Topics: Adult; Aged; Chronic Disease; Diagnosis, Differential; Diuretics; Dyspnea; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Torsemide | 2014 |
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
Topics: Academic Medical Centers; Aged; Comorbidity; Databases, Factual; Female; Furosemide; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; North Carolina; Retrospective Studies; Risk Factors; Sex Factors; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Tertiary Care Centers; Torsemide; Treatment Outcome; Ultrasonography | 2015 |
Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
Topics: Animals; Cardiovascular Agents; Clinical Decision-Making; Fibrosis; Heart Failure; Humans; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Patient Selection; Precision Medicine; Proteins; Sulfonamides; Torsemide; Ventricular Remodeling | 2016 |
Comparative effects of torasemide and furosemide on gap junction proteins and cardiac fibrosis in a rat model of dilated cardiomyopathy.
Topics: Animals; Cadherins; Cardiac Myosins; Cardiomyopathy, Dilated; Connexin 43; Connexins; Disease Models, Animal; Furosemide; Gene Expression Regulation; Heart Failure; Humans; Rats; Sulfonamides; Swine; Torsemide | 2017 |
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.
Topics: Ambulatory Care; Ambulatory Care Facilities; Antihypertensive Agents; Bumetanide; Comorbidity; Diuretics; Female; Furosemide; Health Status Indicators; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2008 |
Loop diuretics in patients with heart failure: time to change to torsemide?
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2009 |
[Effects of various diuretics on cardiac function in rats with heart failure].
Topics: Animals; Cytochrome P-450 CYP11B2; Disease Models, Animal; Diuretics; Furosemide; Heart Failure; Hemodynamics; Male; Myocardium; Rats; Rats, Inbred Lew; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2009 |
Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?
Topics: Biomarkers; Diuretics; Heart Failure; Humans; Kidney; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Sulfonamides; Systole; Torsemide; Ventricular Dysfunction, Left | 2010 |
Use of the loop diuretic torsemide in three dogs with advanced heart failure.
Topics: Animals; Diuretics; Dog Diseases; Dogs; Euthanasia, Animal; Fatal Outcome; Female; Furosemide; Heart Failure; Male; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide | 2011 |
Torasemide in chronic heart failure: results of the TORIC study.
Topics: Aged; Chronic Disease; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Potassium; Product Surveillance, Postmarketing; Stroke Volume; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome; Ventricular Function, Left | 2002 |
[Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cost-Benefit Analysis; Diuretics; Female; Furosemide; Germany; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Retrospective Studies; Sulfonamides; Switzerland; Torsemide | 2002 |
[A better diuretic for patients with heart failure. Better control of potassium loss].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Sulfonamides; Torsemide; Treatment Outcome | 2002 |
[Which loop diuretic for heart failure? For prognosis the choices are not all the same].
Topics: Chronic Disease; Diuretics; Furosemide; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic; Sulfonamides; Survival Rate; Torsemide | 2002 |
[Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Furosemide; Heart Failure; Hospital Costs; Humans; Length of Stay; Sulfonamides; Torsemide | 2003 |
[Hear failure. Indications for diuretic therapy in general practice].
Topics: Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide; Water-Electrolyte Balance | 2003 |
[Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].
Topics: Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Myocardial Contraction; Prognosis; Sulfonamides; Torsemide; Treatment Outcome | 2003 |
[Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].
Topics: Chronic Disease; Clinical Trials as Topic; Diuretics; Furosemide; Heart Failure; Humans; Hypokalemia; Prognosis; Sulfonamides; Time Factors; Torsemide | 2003 |
[Heart failure therapy. Cheap can become expensive].
Topics: Clinical Trials as Topic; Cost Savings; Diuretics; Drug Costs; Furosemide; Germany; Heart Failure; Humans; Patient Readmission; Sulfonamides; Survival Analysis; Torsemide | 2003 |
Relation of loop diuretic dose to mortality in advanced heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide | 2006 |
Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bumetanide; California; Creatinine; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Sulfonamides; Survival Analysis; Torsemide; Ventricular Dysfunction, Left | 2006 |
Comparative effects of torasemide and furosemide in rats with heart failure.
Topics: Animals; Collagen Type III; Cytochrome P-450 CYP11B2; Diuretics; Furosemide; Heart Failure; Immunohistochemistry; Male; Myocardium; Rats; Rats, Inbred Lew; Sulfonamides; Survival Rate; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left | 2008 |
Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.
Topics: Animals; Atrial Natriuretic Factor; Body Weight; Cardiomyopathy, Dilated; Collagen Type III; Disease Progression; Diuretics; Heart Failure; Male; Matrix Metalloproteinase 9; Myocarditis; Myocardium; Rats; Rats, Inbred Lew; RNA, Messenger; Sulfonamides; Torsemide; Transforming Growth Factor beta1; Ventricular Function, Left | 2008 |
Pharmacologic approaches for volume excess in acute kidney injury (AKI).
Topics: Acute Kidney Injury; Ascites; Bumetanide; Diuretics; Fluid Therapy; Furosemide; Heart Failure; Hepatorenal Syndrome; Humans; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Natriuretic Agents; Nephrotic Syndrome; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Ultrafiltration; Water-Electrolyte Imbalance | 2008 |
Efficacy and safety of torasemide in children with heart failure.
Topics: Child, Preschool; Chronic Disease; Diuretics; Female; Heart Failure; Humans; Infant; Infant, Newborn; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Prospective Studies; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2008 |
Torsemide (Demadex)--a new loop diuretic.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Diuretics; Edema; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Liver Diseases; Sulfonamides; Torsemide | 1994 |
[Torasemide in patients with chronic heart failure. Results of clinical administration in general practice].
Topics: Adult; Aged; Chronic Disease; Diuretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides; Torsemide | 1996 |
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
Topics: Aged; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Severity of Illness Index; Sulfonamides; Torsemide | 1998 |
Vasculitis with acute kidney failure and torasemide.
Topics: Aged; Antihypertensive Agents; Diuretics; Heart Failure; Humans; Male; Renal Insufficiency; Sulfonamides; Torsemide; Vasculitis, Leukocytoclastic, Cutaneous | 1998 |
Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Cost Control; Diuretics; Drug Costs; Drug Utilization Review; Female; Furosemide; Health Care Costs; Heart Failure; Hospitalization; Humans; Male; Managed Care Programs; Middle Aged; Patient Compliance; Sulfonamides; Torsemide | 1996 |
Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Diuretics; Endothelium, Vascular; Epithelium; Epoprostenol; Female; Furosemide; Heart Failure; Hemodynamics; Humans; In Vitro Techniques; Kidney; Male; Middle Aged; Sulfonamides; Thromboxane B2; Torsemide; Vasodilator Agents | 1999 |
Comparison of therapies with torasemide or furosemide in patients with congestive heart failure from a pharmacoeconomic viewpoint.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Cross-Sectional Studies; Diuretics; Economics, Pharmaceutical; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides; Torsemide | 1998 |
[Decreased mortality. Help for the failing heart].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide; Treatment Outcome | 2000 |
[Pharmaco-economics of heart failure. The proper diuretic helps reduce costs].
Topics: Cost Savings; Diuretics; Drug Costs; Germany; Heart Failure; Humans; Patient Readmission; Sulfonamides; Torsemide | 2000 |
Torasemide: a pharmacoeconomic review of its use in chronic heart failure.
Topics: Chronic Disease; Clinical Trials as Topic; Costs and Cost Analysis; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |
Optimal diuretic therapy for heart failure.
Topics: Biological Availability; Diuretics; Furosemide; Heart Failure; Humans; Sulfonamides; Torsemide | 2001 |
[Diuretics in heart failure. Can they also prolong life?].
Topics: Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Sulfonamides; Survival Rate; Torsemide | 2001 |
[Which diuretic in heart failure? For the prognosis, they are not all equal].
Topics: Clinical Trials as Topic; Diuretics; Edema, Cardiac; Heart Failure; Humans; Prognosis; Sulfonamides; Torsemide; Treatment Outcome | 2002 |